SE9603669D0 - New combination - Google Patents
New combinationInfo
- Publication number
- SE9603669D0 SE9603669D0 SE9603669A SE9603669A SE9603669D0 SE 9603669 D0 SE9603669 D0 SE 9603669D0 SE 9603669 A SE9603669 A SE 9603669A SE 9603669 A SE9603669 A SE 9603669A SE 9603669 D0 SE9603669 D0 SE 9603669D0
- Authority
- SE
- Sweden
- Prior art keywords
- active ingredient
- new combination
- kit
- composition
- salt
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 abstract 4
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 1
- 229960004436 budesonide Drugs 0.000 abstract 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002848 formoterol Drugs 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a composition or kit having as a first active ingredient formoterol, or a salt or solvate derivative thereof, and having as a second active ingredient budesonide, wherein the molar ratio of the first active ingredient to the second active ingredient is from 1:30 to 1:36, and the use of the composition and kit in the treatment of respiratory disorders.
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603669A SE9603669D0 (en) | 1996-10-08 | 1996-10-08 | New combination |
JP10517442A JP2000502365A (en) | 1996-10-08 | 1997-09-24 | New combinations |
KR1019980704266A KR19990071975A (en) | 1996-10-08 | 1997-09-24 | New complex composition |
SK751-98A SK75198A3 (en) | 1996-10-08 | 1997-09-24 | Pharmaceutical composition |
BR9706822A BR9706822A (en) | 1996-10-08 | 1997-09-24 | Process kit composition for treatment of a respiratory disorder and use of the formoterol kit composition of a pharmaceutically acceptable salt or solvate of it and budesonide |
EP97944242A EP0871450A1 (en) | 1996-10-08 | 1997-09-24 | New combination |
AU45782/97A AU715319B2 (en) | 1996-10-08 | 1997-09-24 | New combination |
PCT/SE1997/001606 WO1998015280A1 (en) | 1996-10-08 | 1997-09-24 | New combination |
PL97327037A PL327037A1 (en) | 1996-10-08 | 1997-09-24 | Novel combination |
CA002239308A CA2239308A1 (en) | 1996-10-08 | 1997-09-24 | New combination |
NZ330482A NZ330482A (en) | 1996-10-08 | 1997-09-24 | Compositions comprising formoterol and budesonide for treating respiratory disorders |
CZ981761A CZ176198A3 (en) | 1996-10-08 | 1997-09-24 | Novel preparation |
HU9901674A HUP9901674A3 (en) | 1996-10-08 | 1997-09-24 | New pharmaceutical combination |
TW086114371A TW470647B (en) | 1996-10-08 | 1997-10-02 | Composition and pharmaceutical combination kit comprising formoterol and budesonide |
ZA9708889A ZA978889B (en) | 1996-10-08 | 1997-10-03 | New combination of steroids. |
ARP970104615A AR013614A1 (en) | 1996-10-08 | 1997-10-07 | NEW COMPOSITION THAT INCLUDES A COMBINATION OF STEROIDS, A KIT THAT CONTAINS IT, THE USE OF THE SAME, THE USE OF SUCH KIT OF FORMOTEROL AND DEBUDESONIDA IN THE MANUFACTURE OF A MEDICINAL PRODUCT |
MYPI97004698A MY128337A (en) | 1996-10-08 | 1997-10-07 | New combination of steroids |
NO982414A NO982414L (en) | 1996-10-08 | 1998-05-27 | New combination |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9603669A SE9603669D0 (en) | 1996-10-08 | 1996-10-08 | New combination |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9603669D0 true SE9603669D0 (en) | 1996-10-08 |
Family
ID=20404167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9603669A SE9603669D0 (en) | 1996-10-08 | 1996-10-08 | New combination |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0871450A1 (en) |
JP (1) | JP2000502365A (en) |
KR (1) | KR19990071975A (en) |
AR (1) | AR013614A1 (en) |
AU (1) | AU715319B2 (en) |
BR (1) | BR9706822A (en) |
CA (1) | CA2239308A1 (en) |
CZ (1) | CZ176198A3 (en) |
HU (1) | HUP9901674A3 (en) |
MY (1) | MY128337A (en) |
NO (1) | NO982414L (en) |
NZ (1) | NZ330482A (en) |
PL (1) | PL327037A1 (en) |
SE (1) | SE9603669D0 (en) |
SK (1) | SK75198A3 (en) |
TW (1) | TW470647B (en) |
WO (1) | WO1998015280A1 (en) |
ZA (1) | ZA978889B (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5983956A (en) * | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
SE9700136D0 (en) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
US5980949A (en) * | 1994-10-03 | 1999-11-09 | Astra Aktiebolag | Formulation for inhalation |
SE9700134D0 (en) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
SE9700135D0 (en) | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
SE9700133D0 (en) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
ID24063A (en) * | 1997-06-27 | 2000-07-06 | Astra Ab | ANTI ASMA MEDICINE COMBINATIONS |
SE9703407D0 (en) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (en) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
SE9900834D0 (en) * | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
DE19921693A1 (en) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects |
ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
GB0009584D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
GB0012260D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
FI20002216A0 (en) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Combination particles for asthma therapy |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
SE0200312D0 (en) | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
SE527069C2 (en) | 2003-06-19 | 2005-12-13 | Mederio Ag | Method and apparatus for administering drug powder |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20050026887A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a steroid |
DK2054042T3 (en) | 2006-06-30 | 2020-08-03 | Iceutica Pty Ltd | Processes for the preparation of biologically active compounds in nanoparticle form |
MX2009008794A (en) | 2007-02-19 | 2009-08-25 | Cipla Ltd | Pharmaceutical combinations. |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
CN107412212B (en) | 2009-05-29 | 2021-01-22 | 珍珠治疗公司 | Pulmonary delivery of long-acting muscarinic antagonists and long-acting beta2Compositions of adrenergic receptor agonists and related methods and systems |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
HUE055562T2 (en) | 2011-11-23 | 2021-11-29 | Therapeuticsmd Inc | Natural combination hormone replacement formulations and therapies |
CN107875127A (en) * | 2012-02-28 | 2018-04-06 | 艾塞尤提卡控股公司 | Inhalable drug composition |
ITMI20130571A1 (en) | 2013-04-10 | 2014-10-11 | Zambon Spa | PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU673660C (en) * | 1991-12-18 | 2002-07-25 | Astrazeneca Ab | New combination of formoterol and budesonide |
-
1996
- 1996-10-08 SE SE9603669A patent/SE9603669D0/en unknown
-
1997
- 1997-09-24 WO PCT/SE1997/001606 patent/WO1998015280A1/en not_active Application Discontinuation
- 1997-09-24 HU HU9901674A patent/HUP9901674A3/en unknown
- 1997-09-24 NZ NZ330482A patent/NZ330482A/en unknown
- 1997-09-24 CZ CZ981761A patent/CZ176198A3/en unknown
- 1997-09-24 AU AU45782/97A patent/AU715319B2/en not_active Ceased
- 1997-09-24 KR KR1019980704266A patent/KR19990071975A/en not_active Withdrawn
- 1997-09-24 JP JP10517442A patent/JP2000502365A/en active Pending
- 1997-09-24 SK SK751-98A patent/SK75198A3/en unknown
- 1997-09-24 PL PL97327037A patent/PL327037A1/en unknown
- 1997-09-24 BR BR9706822A patent/BR9706822A/en not_active IP Right Cessation
- 1997-09-24 EP EP97944242A patent/EP0871450A1/en not_active Withdrawn
- 1997-09-24 CA CA002239308A patent/CA2239308A1/en not_active Abandoned
- 1997-10-02 TW TW086114371A patent/TW470647B/en not_active IP Right Cessation
- 1997-10-03 ZA ZA9708889A patent/ZA978889B/en unknown
- 1997-10-07 MY MYPI97004698A patent/MY128337A/en unknown
- 1997-10-07 AR ARP970104615A patent/AR013614A1/en not_active Application Discontinuation
-
1998
- 1998-05-27 NO NO982414A patent/NO982414L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9901674A2 (en) | 1999-09-28 |
CA2239308A1 (en) | 1998-04-16 |
TW470647B (en) | 2002-01-01 |
SK75198A3 (en) | 1998-11-04 |
AU4578297A (en) | 1998-05-05 |
PL327037A1 (en) | 1998-11-09 |
NO982414D0 (en) | 1998-05-27 |
WO1998015280A1 (en) | 1998-04-16 |
MY128337A (en) | 2007-01-31 |
BR9706822A (en) | 1999-03-23 |
NO982414L (en) | 1998-05-27 |
NZ330482A (en) | 1999-11-29 |
CZ176198A3 (en) | 1998-09-16 |
AU715319B2 (en) | 2000-01-20 |
AR013614A1 (en) | 2001-01-10 |
JP2000502365A (en) | 2000-02-29 |
HUP9901674A3 (en) | 2001-04-28 |
EP0871450A1 (en) | 1998-10-21 |
KR19990071975A (en) | 1999-09-27 |
ZA978889B (en) | 1998-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9603669D0 (en) | New combination | |
ATE390133T1 (en) | GABAPENTINE ANALOGUES FOR SLEEP DISORDERS | |
ES2182357T3 (en) | NEW USE OF BUDESONIDE AND FORMOTEROL. | |
DE69721766D1 (en) | NEW MEDICAL FORMULATION | |
WO2002036562A3 (en) | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands | |
CA2259621A1 (en) | Isocoumarin derivatives and their use in medicines | |
CA2222676A1 (en) | New pharmaceutical composition with anaesthetic effect | |
BR9711194A (en) | Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease. | |
CY1108610T1 (en) | IL-2 Peptides and their derivatives and their use as therapeutic agents | |
WO2003053359A3 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
GB0005251D0 (en) | Therapeutic compounds | |
EE05661B1 (en) | Use of a Formoterol and Budesonide Composition for the Prevention or Treatment of Asthma-Related Conditions | |
CA2199844A1 (en) | Compositions for the treatment of skin disorders | |
SE9704644D0 (en) | New use | |
ATE226084T1 (en) | WOUND HEALING AND TREATMENT OF FIBROSIS | |
MD502G2 (en) | New adenozine derivatives, methods of obtainitg thereof, farmaceutical compositions on the base thereof | |
HUP9902415A2 (en) | Solid instant-release forms of administration and process for producing the same | |
BG102667A (en) | Diosgenine-containing composition | |
ATE201680T1 (en) | 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE ACID ADDITION SALTS | |
BR9808299A (en) | The use of levobupivacaìna or ropivacaìna for the treatment of migraine | |
EP0373771A3 (en) | New pharmaceutical uses for cystatins | |
TWI262791B (en) | 6-methoxy-2-naphthylacetic acid prodrugs | |
ID26132A (en) | MAKING FOR TREATMENT OF ERROR FUNCTION INTERFERENCE | |
DE59705183D1 (en) | THERAPEUTIC AGENTS, CONTAINING LEAVES AGAINST ASTHMA | |
WO2000002877A3 (en) | New pharmaceutically active compounds |